Published 5 days ago • loading... • Updated 5 days ago

Biotech might be tiny but the dealmaking is mighty

Summary by STAT

Also this week: A look at Kura and Syndax as they vie for market share among AML patients, and why Intellia faces an existential crisis.

Also this week: A look at Kura and Syndax as they vie for market share among AML patients, and why Intellia faces an existential crisis.

5 days ago·Boston, United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right0Center1Last Updated5 days agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

STAT broke the news in Boston, United States 5 days ago on Thursday, October 30, 2025.

Sources are mostly out of (0)